{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:27:53Z","timestamp":1794245273951,"version":"4.9.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008321","name":"Pennsylvania State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/00433\u20138"],"award-info":[{"award-number":["2020\/00433\u20138"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["404067\/2012\u20133"],"award-info":[{"award-number":["404067\/2012\u20133"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CBB-APQ 00952\u201316"],"award-info":[{"award-number":["CBB-APQ 00952\u201316"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijpddr.2020.12.001","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T19:11:29Z","timestamp":1607195489000},"page":"9-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-9090","authenticated-orcid":false,"given":"Marcelo U.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tais","family":"Nobrega de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8208-2817","authenticated-orcid":false,"given":"Gabriel W.","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5360-3740","authenticated-orcid":false,"given":"Igor C.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-2200","authenticated-orcid":false,"given":"Rodrigo M.","family":"Corder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ladeia-Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Pedro","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.12.001_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002299","article-title":"Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial","volume":"14","author":"Abreha","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2125.1998.00765.x","article-title":"Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail","volume":"46","author":"Adedoyin","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003595","article-title":"Modelling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo","volume":"9","author":"Adekunle","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2875-13-73","article-title":"Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rond\u00f4nia, West Amazon, Brazil","volume":"13","author":"Aguiar","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib5","article-title":"Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients","author":"Almeida","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib6","first-page":"301","article-title":"Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine","volume":"46","author":"Alving","year":"1955","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib7","first-page":"621","article-title":"Mitigation of the hemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: a preliminary report","volume":"22","author":"Alving","year":"1960","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/jiw323","article-title":"Genomic analysis reveals a common breakpoint in amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand","volume":"214","author":"Auburn","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12936-018-2433-z","article-title":"Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry","volume":"17","author":"Avula","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib10","doi-asserted-by":"crossref","first-page":"e00011","DOI":"10.1128\/CMR.00011-19","article-title":"8-Aminoquinoline therapy for latent malaria","volume":"32","author":"Baird","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12936-018-2190-z","article-title":"Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms","volume":"17","author":"Baird","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"Baird","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4269\/ajtmh.1997.56.621","article-title":"Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels","volume":"56","author":"Baird","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1449","article-title":"Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria","volume":"1","author":"Baird","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"6 Suppl. l","key":"10.1016\/j.ijpddr.2020.12.001_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4269\/ajtmh.16-0171","article-title":"Diagnosis and treatment of Plasmodium vivax malaria","volume":"95","author":"Baird","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib16","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1128\/AAC.00578-08","article-title":"Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes","volume":"52","author":"Barnadas","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","article-title":"Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study","volume":"394","author":"Battle","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1301936","article-title":"Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria","volume":"369","author":"Bennett","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib19","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/infdis\/jis580","article-title":"Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age","volume":"206","author":"Betuela","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJM199101173240306","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"324","author":"Beutler","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1073\/pnas.48.1.9","article-title":"The normal human female as a mosaic of X-chromosome activity: studies using the gene for C-6-PD-deficiency as a marker","volume":"48","author":"Beutler","year":"1962","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12936-017-2139-7","article-title":"CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study","volume":"17","author":"Brasil","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1086\/426830","article-title":"Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity","volume":"191","author":"Brega","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002882","article-title":"A high-resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings","volume":"8","author":"Bright","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib25","series-title":"Chemotherapy of Malaria","year":"1986"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12936-017-2034-2","article-title":"Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia","volume":"16","author":"Chaorattanakawee","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1475-2875-12-226","article-title":"In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon","volume":"12","author":"Chehuan","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14787210.2016.1220304","article-title":"Management of relapsing Plasmodium vivax malaria","volume":"14","author":"Chu","year":"2016","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1473-3099(18)30348-7","article-title":"The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis","volume":"18","author":"Commons","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib30","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4269\/ajtmh.20-0186","article-title":"Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis","volume":"103","author":"Commons","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0940-2993(99)80010-4","article-title":"Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine","volume":"51","author":"Constantino","year":"1999","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008526","article-title":"Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: an observational and modeling study in Brazil","volume":"14","author":"Corder","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007377","article-title":"Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: a case study in the Amazon Basin","volume":"16","author":"Corder","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12936-017-1806-z","article-title":"Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature","volume":"16","author":"Costa","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-018-0563-0","article-title":"Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing","volume":"10","author":"Cowell","year":"2018","journal-title":"Genome Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-3156.2001.00819.x","article-title":"History and importance of antimalarial drug resistance","volume":"6","author":"D'Alessandro","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049871","article-title":"Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection","volume":"7","author":"de Araujo","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008808","article-title":"Population genomics reveals the expansion of highly inbred Plasmodium vivax lineages in the main malaria hotspot of Brazil","volume":"14","author":"de Oliveira","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005824","article-title":"Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax","volume":"11","author":"de Oliveira","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12936-015-0846-5","article-title":"Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology","volume":"14","author":"de Souza","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib41","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(01)06040-8","article-title":"Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria","volume":"358","author":"Djimd\u00e9","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/inthealth\/ihy060","article-title":"Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities","volume":"11","author":"Domingo","year":"2019","journal-title":"Int. Health"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002379","article-title":"Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study","volume":"14","author":"Douglas","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.2001.65.471","article-title":"Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria","volume":"65","author":"Duarte","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib45","first-page":"285","article-title":"Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report","volume":"9","author":"Edgcomb","year":"1950","journal-title":"J. Natl. Malar. Soc."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1475-2875-10-351","article-title":"Primaquine in vivax malaria: an update and review on management issues","volume":"10","author":"Fernando","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jpm8020015","article-title":"Ten years' experience with the CYP2D6 activity score: a perspective on future investigations to improve clinical predictions for precision therapeutics","volume":"8","author":"Gaedigk","year":"2018","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/gim.2016.80","article-title":"Prediction of CYP2D6 phenotype from genotype across world populations","volume":"19","author":"Gaedigk","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.clpt.6100406","article-title":"The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype","volume":"83","author":"Gaedigk","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib51","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1128\/AAC.02050-12","article-title":"In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes","volume":"57","author":"Ganguly","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.76.203","article-title":"Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy","volume":"76","author":"Goller","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib53","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1590\/0074-0276130579","article-title":"Emerging Plasmodium vivax resistance to chloroquine in South America: an overview","volume":"109","author":"Gon\u00e7alves","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib54","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4269\/ajtmh.2010.09-0521","article-title":"Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon","volume":"82","author":"Grietens","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib55","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1086\/381397","article-title":"Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulphadoxine plus pyrimethamine","volume":"189","author":"Hastings","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.exppara.2008.08.012","article-title":"Plasmodium vivax: microsatellite analysis of multiple-clone infections","volume":"120","author":"Havryliuk","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1389200215666140202215316","article-title":"Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization","volume":"15","author":"Hicks","year":"2014","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","article-title":"Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I","volume":"75","author":"Hill","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map","volume":"9","author":"Howes","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12936-017-1912-y","article-title":"Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow","volume":"16","author":"Htun","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/infdis\/jir806","article-title":"The first Plasmodium vivax relapses of life are usually genetically homologous","volume":"205","author":"Imwong","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib62","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.45.11.3122-3127.2001","article-title":"Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulphadoxine-pyrimethamine: geographical and clinical correlates","volume":"45","author":"Imwong","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib63","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1128\/AAC.01459-07","article-title":"Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar","volume":"52","author":"Imwong","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib64","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/512241","article-title":"Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites","volume":"195","author":"Imwong","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity","volume":"5","author":"Ingelman-Sundberg","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1475-2875-13-488","article-title":"The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea","volume":"13","author":"Ingram","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2133\/dmpk.25.243","article-title":"Estimation of the interindividual variability of cytochrome 2D6 activity from urinary metabolic ratios in the literature","volume":"25","author":"Ito","year":"2010","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/00034983.1994.11812860","article-title":"Removal of leucocytes from Plasmodium vivax-infected blood","volume":"88","author":"Janse","year":"1994","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1475-2875-11-280","article-title":"Primaquine radical cure of Plasmodium vivax: a critical review of the literature","volume":"11","author":"John","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12936-018-2188-6","article-title":"Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India","volume":"17","author":"Joy","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib71","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3201\/eid2010.140411","article-title":"Effects of mefloquine use on Plasmodium vivax multidrug resistance","volume":"20","author":"Khim","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib72","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/597303","article-title":"Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials","volume":"199","author":"Koepfli","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exppara.2006.02.006","article-title":"Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates","volume":"114","author":"Kosaisavee","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1710775","article-title":"Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria","volume":"380","author":"Lacerda","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01965-18","article-title":"Monitoring the efficacy of chloroquine-primaquine therapy for uncomplicated Plasmodium vivax malaria in the main transmission hot spot of Brazil","volume":"63","author":"Ladeia-Andrade","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2042-7158.1990.tb05405.x","article-title":"Inhibition of metoprolol metabolism by chloroquine and other antimalarial drugs","volume":"42","author":"Lancaster","year":"1990","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib77","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008255","article-title":"Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes","volume":"14","author":"Li","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib79","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/infdis\/jiw303","article-title":"Reticulocyte preference and stage development of Plasmodium vivax isolates","volume":"214","author":"Lim","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib80","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ajh.24383","article-title":"Improved light microscopy counting method for accurately counting Plasmodium parasitemia and reticulocytemia","volume":"91","author":"Lim","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib81","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/infdis\/jiv142","article-title":"Using amplicon deep sequencing to detect genetic signatures of Plasmodium vivax relapse","volume":"212","author":"Lin","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib82","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","article-title":"Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study","volume":"383","author":"Llanos-Cuentas","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria","volume":"380","author":"Llanos-Cuentas","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib84","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/tpj.2010.85","article-title":"CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans","volume":"12","author":"Llerena","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005806","article-title":"Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes","volume":"11","author":"Lo","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib86","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12879-016-1482-6","article-title":"Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction","volume":"16","author":"Lo","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib87","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/1471-2334-14-539","article-title":"The distribution of incubation and relapse times in experimental human infections with the malaria parasite Plasmodium vivax","volume":"14","author":"Lover","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2010.08.011","article-title":"Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries","volume":"117","author":"Lu","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib89","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3347\/kjp.2012.50.4.379","article-title":"Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China","volume":"50","author":"Lu","year":"2012","journal-title":"Kor. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib90","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1086\/501357","article-title":"Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia","volume":"42","author":"Maguire","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib91","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/jis747","article-title":"Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms","volume":"207","author":"Malmberg","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.011","article-title":"Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art","volume":"161","author":"Marcsisin","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2875-13-2","article-title":"Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds","volume":"13","author":"Marcsisin","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib94","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/AAC.02279-12","article-title":"Plasmodium vivax chloroquine resistance and anemia in the western Brazilian Amazon","volume":"58","author":"Marques","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105922","article-title":"Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon","volume":"9","author":"Melo","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib96","doi-asserted-by":"crossref","first-page":"a025619","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib97","doi-asserted-by":"crossref","first-page":"e01500","DOI":"10.1128\/AAC.01500-16","article-title":"Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphic markers","volume":"61","author":"Messerli","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib98","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2125.1985.tb02709.x","article-title":"Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size","volume":"19","author":"Mihaly","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib99","first-page":"CD012656","article-title":"Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax","volume":"8","author":"Milligan","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12936-016-1632-8","article-title":"Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei","volume":"15","author":"Milner","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib101","doi-asserted-by":"crossref","first-page":"e02116","DOI":"10.1128\/AAC.02116-18","article-title":"Emergence of Plasmodium vivax resistance to chloroquine in French Guiana","volume":"63","author":"Musset","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib102","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2307\/3284254","article-title":"Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys","volume":"83","author":"Nayar","year":"1997","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib103","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4269\/ajtmh.16-0075","article-title":"Efficacy of chloroquine and primaquine for the treatment of uncomplicated Plasmodium vivax malaria in Cruzeiro do Sul, Brazil","volume":"95","author":"Negreiros","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib104","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12916-015-0535-9","article-title":"Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia","volume":"13","author":"Nelwan","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib105","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/cpt.1032","article-title":"CYP2D6 protein level Is the major contributor to interindividual variability in CYP2D6-mediated drug metabolism in healthy human liver tissue","volume":"104","author":"Ning","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib106","first-page":"2589","article-title":"Close kinship within multiple-genotype malaria parasite infections","volume":"279","author":"Nkhoma","year":"2012","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib107","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1086\/320707","article-title":"Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria","volume":"183","author":"Nomura","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib108","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1128\/AAC.00004-09","article-title":"Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region","volume":"53","author":"Orjuela-S\u00e1nchez","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib109","series-title":"Practical Guide for in Vivo Antimalarial Drug-Efficacy Studies in the Americas","year":"2003"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.02207-15","article-title":"Expression of Plasmodium vivax crt-o Is related to parasite stage but not ex vivo chloroquine susceptibility","volume":"60","author":"Pava","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0169-4758(87)90147-5","article-title":"Spread of chloroquine resistance in Plasmodium falciparum","volume":"3","author":"Payne","year":"1987","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib112","article-title":"Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: a systematic review and meta-analysis","volume":"17","author":"Pfeffer","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0882-1","article-title":"Survival analysis of diagnostic assays in Plasmodium falciparum malaria","volume":"14","author":"Phuong","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib114","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/cid\/cir631","article-title":"Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial","volume":"53","author":"Phyo","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib115","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01888-17","article-title":"Genomic analyses reveal the common occurrence and complexity of Plasmodium vivax relapses in Cambodia","volume":"9","author":"Popovici","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib116","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.00015-15","article-title":"Differential CYP 2D6 metabolism alters primaquine pharmacokinetics","volume":"59","author":"Potter","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib117","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.pt.2012.08.005","article-title":"Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax","volume":"28","author":"Price","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib118","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","article-title":"Plasmodium vivax in the era of the shrinking P. falciparum map","volume":"36","author":"Price","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib119","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"Price","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib120","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.44.6.1680-1685.2000","article-title":"Therapeutic responses to different antimalarial drugs in vivax malaria","volume":"44","author":"Pukrittayakamee","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib121","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/AAC.02794-13","article-title":"Pharmacokinetic interactions between primaquine and chloroquine","volume":"58","author":"Pukrittayakamee","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib122","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/infdis\/169.4.932","article-title":"Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria","volume":"169","author":"Pukrittayakamee","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib123","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-12-212","article-title":"The metabolism of primaquine to its active metabolite is dependent on CYP 2D6","volume":"12","author":"Pybus","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1475-2875-11-259","article-title":"CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine","volume":"11","author":"Pybus","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib125","series-title":"Doctoral Dissertation","article-title":"Empowering the experimental biology of Plasmodium Vivax through elucidating requirements for ex vivo culture","author":"Rangel","year":"2019"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib126","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02519-17","article-title":"Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays","volume":"62","author":"Rangel","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib127","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FPC.0000000000000363","article-title":"CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels","volume":"29","author":"Ray","year":"2019","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib128","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(89)91792-3","article-title":"Plasmodium vivax resistance to chloroquine?","volume":"2","author":"Rieckmann","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001891","article-title":"Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model","volume":"12","author":"Robinson","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib130","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/jac\/dkaa092","article-title":"Impact of the first-line treatment shift from dihydroartemisinin\/piperaquine to artesunate\/mefloquine on Plasmodium vivax drug susceptibility in Cambodia","volume":"75","author":"Roesch","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib131","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","article-title":"Hemolytic potential of tafenoquine in female volunteers heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency","volume":"97","author":"Rueangweerayut","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib132","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3347\/kjp.2015.53.1.43","article-title":"Plasmodium vivax drug resistance genes: pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand","volume":"53","author":"Rungsihirunrat","year":"2015","journal-title":"Kor. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib133","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01334-07","article-title":"Determinants of in vitro drug susceptibility testing of Plasmodium vivax","volume":"52","author":"Russell","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib134","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ijpara.2012.08.010","article-title":"Human ex vivo studies on asexual Plasmodium vivax: the best way forward","volume":"42","author":"Russell","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib135","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/s41467-019-12256-9","article-title":"Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross","volume":"10","author":"S\u00e1","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib136","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.exppara.2004.12.005","article-title":"Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains","volume":"109","author":"S\u00e1","year":"2005","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib137","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1475-2875-13-129","article-title":"Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India","volume":"13","author":"Shalini","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib138","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ijpara.2016.06.003","article-title":"Infection of laboratory colonies of Anopheles mosquitoes with Plasmodium vivax from cryopreserved clinical isolates","volume":"46","author":"Shaw-Saliba","year":"2016","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib139","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12936-018-2411-5","article-title":"Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon","volume":"17","author":"Silva","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160172","article-title":"Variation in human cytochrome P-450 drug-metabolism genes: a gateway to the understanding of Plasmodium vivax relapses","volume":"11","author":"Silvino","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib141","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02056-19","article-title":"Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence","volume":"64","author":"Silvino","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib142","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1590\/0102-311X00169312","article-title":"Factors associated with recurrent Plasmodium vivax malaria in Porto Velho, Rond\u00f4nia State, Brazil, 2009","volume":"30","author":"Sim\u00f5es","year":"2014","journal-title":"Cad. Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib143","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/ciw706","article-title":"Fixed-dose artesunate-amodiaquine combination vs chloroquine for treatment of uncomplicated blood stage P. vivax infection in the Brazilian Amazon: an open-label randomized, controlled trial","volume":"64","author":"Siqueira","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib144","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/520154","article-title":"Double-blind, randomized, placebo-controlled assessment of chloroquine\/primaquine prophylaxis for malaria in nonimmune Colombian soldiers","volume":"29","author":"Soto","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib145","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/infdis\/jiz386","article-title":"Determination of cytochrome P450 isoenzyme 2D6 (CYP2D6) genotypes and pharmacogenomic impact on primaquine metabolism in an active-duty US military population","volume":"220","author":"Spring","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib146","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1475-2875-8-115","article-title":"Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood","volume":"8","author":"Sriprawat","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib147","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12936-016-1145-5","article-title":"Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial","volume":"15","author":"St Jean","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib148","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/592451","article-title":"Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax","volume":"198","author":"Suwanarusk","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001089","article-title":"Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms","volume":"2","author":"Suwanarusk","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.19-0706","article-title":"The WorldWide Antimalarial Resistance Network clinical trials publication library: a live, open-access database of Plasmodium treatment efficacy trials","volume":"103","author":"Takata","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib151","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1475-2875-10-251","article-title":"Development and evaluation of a prototype non-woven fabric filter for purification of malaria-infected blood","volume":"10","author":"Tao","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib152","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/s41467-019-13412-x","article-title":"Resolving the cause of recurrent Plasmodium vivax malaria probabilistically","volume":"10","author":"Taylor","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib153","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.actatropica.2016.04.009","article-title":"Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax","volume":"160","author":"Thomas","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib154","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12936-019-2949-x","article-title":"From marginal to essential: the golden thread between nutrient sensing, medium composition and Plasmodium vivax maturation in in vitro culture","volume":"18","author":"Thomson-Luque","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12936-018-2380-8","article-title":"Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group","volume":"17","author":"Thriemer","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib156","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4269\/ajtmh.2010.09-0458","article-title":"High complexity of Plasmodium vivax infections in symptomatic patients from a rural community in central Vietnam detected by microsatellite genotyping","volume":"82","author":"Van den Eede","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib157","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4269\/ajtmh.2012.12-0094","article-title":"Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of Plasmodium vivax: local and global patterns","volume":"87","author":"Vargas-Rodr\u00edguez","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib158","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1016\/S0021-9258(19)50504-X","article-title":"Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling","volume":"267","author":"Vasquez-Vivar","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib159","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-2952(94)90022-1","article-title":"Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo","volume":"47","author":"V\u00e1squez-Vivar","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2875-11-41","article-title":"Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples","volume":"11","author":"Venkatesan","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib161","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00343-15","article-title":"Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics","volume":"59","author":"Vuong","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib162","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/hmg\/ddu566","article-title":"Functional characterization of CYP2D6 enhancer polymorphisms","volume":"24","author":"Wang","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib163","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in Plasmodium vivax malaria","volume":"10","author":"White","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib164","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-397900-1.00002-5","article-title":"Relapse","volume":"80","author":"White","year":"2012","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12936-015-0940-8","article-title":"Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry","volume":"14","author":"Wirjanata","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-17","article-title":"Plasmodium falciparum and Plasmodium vivax demonstrate contrasting chloroquine resistance reversal phenotypes","volume":"61","author":"Wirjanata","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib167","series-title":"Report of a WHO Scientific Group","article-title":"Chemotherapy of malaria","author":"World Health Organization","year":"1967"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib168","series-title":"Guidelines for the Treatment of Malaria","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ijpddr.2020.12.001_bib170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12936-019-2837-4","article-title":"Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis","volume":"18","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib171","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1128\/AAC.04270-14","article-title":"Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar","volume":"59","author":"Yuan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib172","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00210-003-0832-2","article-title":"Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry","volume":"369","author":"Zanger","year":"2004","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib173","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpddr.2020.12.001_bib174","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","article-title":"Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation","volume":"392","author":"Zanger","year":"2008","journal-title":"Anal. Bioanal. Chem."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132072030049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132072030049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:50:26Z","timestamp":1761922226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221132072030049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":173,"alternative-id":["S221132072030049X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.12.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}